31 – 40 of 284
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The complexity of kidney disease and diagnosing it - Cystatin C, selective glomerular hypofiltration syndromes and proteome regulation
(
- Contribution to journal › Scientific review
-
Mark
Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa
(
- Contribution to journal › Article
- 2022
-
Mark
Evaluation of the creatinine-based chronic kidney disease in children (under 25 years) equation in healthy children and adolescents
(
- Contribution to journal › Article
-
Mark
Changes in perceived parental self-efficacy after a Child-Centred Health Dialogue about preventing obesity
(
- Contribution to journal › Article
-
Mark
High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population–first results from a cohort study in Southern Sweden
(
- Contribution to journal › Article
-
Mark
A child‐centered health dialogue for the prevention of obesity in child health services in Sweden – A randomized controlled trial including an economic evaluation
(
- Contribution to journal › Article
-
Mark
Characteristics and severe outcomes of patients presenting to the Emergency Department with dizziness
2022) Swedish Emergency Medicine Talks 2022(
- Contribution to conference › Poster
-
Mark
Surveillance of COVID-19 vaccine effectiveness : A real-time case-control study in southern Sweden
(
- Contribution to journal › Article
-
Mark
Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities - surveillance results from southern Sweden, July 2021 to January 2022
2022) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(9).(
- Contribution to journal › Article
-
Mark
COVID-19 vaccine effectiveness against severe disease from the Omicron BA.1 and BA.2 subvariants: surveillance results from southern Sweden, December 2021 to March 2022
2022)(
- Working paper/Preprint › Preprint in preprint archive